Published in Health and Medicine Week, October 10th, 2005
Since Daiichi launched Omnipaque (Iohexol) in 1987, which is a contrast media for x-ray and computed tomography examinations, under license from GE Healthcare, Daiichi has marketed Omniscan, magnetic resonance imaging contrast media (launched in 1996) and Visipaque, an x-ray contrast media (launched in 2000) in Japan.
In addition to these products licensed, Daiichi has collaborated with GE Healthcare on the research and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week